Cluster 1 exhibited a poor prognosis and was characterized by decreases in the HIPPO-, MYC-, NOTCH-, NRF1-, TGF-beta-, PIK3-, and RAS-associated tumor pathways. This evidence concerns the gene MYC and neoplasm.